Docket Management
Docket: 03N-0059 - Pharmaceutical Current Good Manufacturing Practices for the 21st Century: A Risk-Based Approach
Comment Number: EC -25

Accepted - Volume 1

Comment Record
Commentor Mr. Awanindra Kumar Date/Time 2003-04-12 07:01:45
Organization Dishman pharmaceuticals&chemicals Ltd
Category Company

Comments for FDA General
Questions
1. General Comments THE TEAM OF PI WILL BE TRAINED FOR NEW MANUFACTURING TECHNOLOGIES & IT IS ALSO REQUIRED FOR THE COMPANIES & INDIVIDUALS WHO ARE SEEKING FDA APPROVAL TO GET TRAINED FOR CGMP & NEW TECHNOLOGIES.THE PI CAN DO THE TRAINING PROGRAMME AS WELL AS INSPECTION ON IGH RISK FIRMS




EC -25